Food Allergy‐Induced Systemic Immune Alterations Affect Tumor Progression in a CT26 Colon Adenocarcinoma Mouse Model
Allergy · 2026
DOI: 10.1111/all.70331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, 2026. Verfasst von Xiaoyu Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Food Hypersensitivity, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: The National Natural Science Foundation of China..
Abstract (Originalsprache)
Background
AllergoOncology has emerged as an interdisciplinary field exploring the interaction between allergic diseases and cancer; however, the lack of stable in vivo models has limited mechanistic investigations. This study aimed to establish an experimental animal model to explore the impact of systemic allergic responses on tumor progression and to provide preliminary insights into the regulatory role of allergy in cancer development.
Methods
An ovalbumin (OVA)‐induced systemic allergy tumor‐bearing mouse model (OVA‐TM) was established by OVA sensitization followed by subcutaneous implantation of CT26 colon cancer cells. Tumor growth, immune responses, and behavioral changes were systematically evaluated. Tumor immune microenvironment alterations were assessed using immunological and histological analyses. Transcriptomic profiling and mass spectrometry imaging (MSI) were integrated to investigate immune‐related metabolic alterations. Human tumor survival datasets were used to validate the prognostic relevance of differentially expressed genes (DEGs), and enrichment analyses of allergy‐ and cancer‐associated genes were performed using humanized databases.
Results
OVA‐induced systemic allergy significantly suppressed tumor growth and promoted immune cell infiltration, particularly CD3 + CD8 + T cells. Transcriptomic analysis identified key DEGs, including Aoc1, Apob, Apobec2 , and Acta1 , whose expression correlated with overall survival in multiple cancer types. Integrated transcriptomics and pathway enrichment analysis revealed extensive functional reprogramming in OVA‐TM tumors, including activation of metabolic and immune‐related pathways. Consistent with these findings, spatial metabolomics analysis showed synergistic alterations in lipid and amino acid‐related metabolic pathways in both tumors and the spleen.
Conclusion
This study establishes a practical in vivo model for AllergoOncology and demonstrates that systemic allergic responses can modulate tumor progression through immune activation, apoptosis, and inflammation–metabolism axis reprogramming, providing a foundation for future mechanistic and therapeutic studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Shenyang Pharmaceutical University, Shenyang, China.
- College of Pharmacy, Shanxi University of Traditional Chinese Medicine, Xianyang, China.
- Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing,…
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Key Laboratory for Safety Research and Evaluation of Innovative Drug, National Medical Products Administration, Beijing, China.
ORCID-Profile: Shushu Guo, Yan Li
Förderung
- The National Natural Science Foundation of China.
Zitieren
APA
Fan, X., Guo, S., Zhang, W., Xu, Z., Sun, S., Li, Y., He, J., & Jin, H. (2026). Food Allergy‐Induced Systemic Immune Alterations Affect Tumor Progression in a CT26 Colon Adenocarcinoma Mouse Model. Allergy. https://doi.org/10.1111/all.70331
Vancouver
Fan X, Guo S, Zhang W, Xu Z, Sun S, Li Y, et al. Food Allergy‐Induced Systemic Immune Alterations Affect Tumor Progression in a CT26 Colon Adenocarcinoma Mouse Model. Allergy. 2026. doi:10.1111/all.70331
BibTeX
@article{Fan2026,
author = {Fan, Xiaoyu and Guo, Shushu and Zhang, Wenchao and Xu, Zeao and Sun, Siman and Li, Yan and He, Jiuming and Jin, Hongtao},
title = {Food Allergy‐Induced Systemic Immune Alterations Affect Tumor Progression in a CT26 Colon Adenocarcinoma Mouse Model},
journal = {Allergy},
year = {2026},
doi = {10.1111/all.70331}
}
EUVIMED